Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study.
Circ Cardiovasc Imaging. 2024 Jan;17(1):e016206. doi: 10.1161/CIRCIMAGING.123.016206. Epub 2024 Jan 11.
Circ Cardiovasc Imaging. 2024.
PMID: 38205656
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, Muñiz-Grijalvo O, Mediavilla JD, Argüeso R, Sánchez Muñoz-Torrero JF, Rubio P, Álvarez-Baños P, Ponte P, Mañas D, Suárez Gutierrez L, Cepeda JM, Casañas M, Fuentes F, Guijarro C, Ángel Barba M, Saltijeral Cerezo A, Padró T, Mata P; SAFEHEART Study Group.
Pérez de Isla L, et al. Among authors: alvarez banos p.
Circulation. 2023 May 9;147(19):1436-1443. doi: 10.1161/CIRCULATIONAHA.122.062557. Epub 2023 Apr 3.
Circulation. 2023.
PMID: 37009731
Free PMC article.
Item in Clipboard
Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease.
Gil-Polo C, Martinez-Horta SI, Sampedro Santalo F, Martín-Palencia M, Gundín-Menéndez S, Alvarez-Baños P, Maza-Pereg L, Calvo S, Collazo C, Alonso-García E, Riñones-Mena E, Arrabal-Alonso A, Núñez Rodriguez J, Saiz-Rodriguez M, Aguado L, Mariscal N, Muñoz-Siscart I, Piñeiro D, Rivadeneyra J, Diez-Fairen M, Miguel-Pérez I, Cubo E.
Gil-Polo C, et al. Among authors: alvarez banos p.
Mov Disord Clin Pract. 2022 Dec 10;10(2):279-284. doi: 10.1002/mdc3.13613. eCollection 2023 Feb.
Mov Disord Clin Pract. 2022.
PMID: 36825059
Free PMC article.
Item in Clipboard
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study.
Alonso R, Arroyo-Olivares R, Muñiz-Grijalvo O, Díaz-Díaz JL, Muñoz-Torrero JS, Romero MJ, de Andrés R, Zambón D, Mañas MD, Fuentes-Jiménez F, Aguado R, Alvarez-Baños P, Arrieta F, Gonzalez-Bustos P, Cepeda J, Martin-Ordiales M, Mosquera D, Michan A, de Isla LP, Argueso R, Mata P.
Alonso R, et al. Among authors: alvarez banos p.
Eur J Prev Cardiol. 2023 Mar 1;30(4):320-328. doi: 10.1093/eurjpc/zwac277.
Eur J Prev Cardiol. 2023.
PMID: 36416136
Item in Clipboard
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients.
Pérez de Isla L, Alonso R, Argüeso R, Muñiz-Grijalvo O, Álvarez-Baños P, Badimón L, Watts GF, Mata P; SAFEHEART Investigators.
Pérez de Isla L, et al. Among authors: alvarez banos p.
J Clin Lipidol. 2022 Sep-Oct;16(5):733-736. doi: 10.1016/j.jacl.2022.07.007. Epub 2022 Jul 18.
J Clin Lipidol. 2022.
PMID: 35906178
Item in Clipboard
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
Alonso R, Argüeso R, Álvarez-Baños P, Muñiz-Grijalvo O, Diaz-Diaz JL, Mata P.
Alonso R, et al. Among authors: alvarez banos p.
Curr Atheroscler Rep. 2022 Jun;24(6):427-434. doi: 10.1007/s11883-022-01019-5. Epub 2022 Apr 7.
Curr Atheroscler Rep. 2022.
PMID: 35386090
Review.
Item in Clipboard
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience.
Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, de Andrés R, Arroyo-Olivares R, Fuentes-Jimenez F, Muñoz-Torrero JS, Cepeda J, Aguado R, Alvarez-Baños P, Casañas M, Dieguez M, Mañas MD, Rubio P, Argueso R, Arrieta F, Gonzalez-Bustos P, Perez-Isla L, Mata P; SAFEHEART investigators.
Alonso R, et al. Among authors: alvarez banos p.
J Clin Lipidol. 2021 Jul-Aug;15(4):584-592. doi: 10.1016/j.jacl.2021.04.011. Epub 2021 May 7.
J Clin Lipidol. 2021.
PMID: 34052174
Item in Clipboard
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
Pérez de Isla L, Arroyo-Olivares R, Muñiz-Grijalvo O, Diaz-Díaz JL, Zambón D, Fuentes F, Sánchez Muñoz-Torrero JF, Mediavilla JD, González-Estrada A, Miramontes-González JP, de Andrés R, Mauri M, Mosquera D, Cepeda JM, Suárez L, Barba-Romero MÁ, Argüeso R, Álvarez-Baños P, Michán A, Romero-Jiménez MJ, García-Cruces J, Padró T, Alonso R, Mata P.
Pérez de Isla L, et al. Among authors: alvarez banos p.
J Clin Lipidol. 2019 Nov-Dec;13(6):989-996. doi: 10.1016/j.jacl.2019.10.005. Epub 2019 Oct 11.
J Clin Lipidol. 2019.
PMID: 31706904
Free article.
Item in Clipboard
Cite
Cite